Responses
Diagnosis
Systematic review
Meta-analysis finds screening for prostate cancer with PSA does not reduce prostate cancer–related or all-cause mortality but results likely due to heterogeneity – the two highest quality studies identified do find prostate cancer–related mortality reductions
Compose a Response to This Article
Other responses
No responses have been published for this article.